Trastuzumab and enterocolitis Patient Reports February 09, 2010

Trastuzumab Side Effects Report #5718504-8
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 11, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: enterocolitis. Trastuzumab dosage: 186 MG, QD. During the same period patient was treated with TAXOTERE, DESYREL, SEPAZON, ROHYPNOL, TAGAMET, DOXAZOSIN MESYLATE, NORVASC, CALONAL. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5724173-3
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 16, 2008. Female patient was diagnosed with breast cancer metastatic, depression , gastric ulcer, hypertension, hypoaesthesia, headache  and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: enterocolitis. Trastuzumab dosage: 186 MG, QD. During the same period patient was treated with TAXOTERE, SEPAZON, TAGAMET, DOXAZOSIN MESYLATE, NORVASC, DEPAS, ACETAMINOPHEN, DECADRON. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5830457-0
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 18, 2008. Female patient was diagnosed with breast cancer metastatic, depression , gastric ulcer, hypertension, hypoaesthesia, headache  and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: enterocolitis. Trastuzumab dosage: 186 MG, QD. During the same period patient was treated with TAXOTERE, SEPAZON, TAGAMET, DOXAZOSIN MESYLATE, NORVASC, DEPAS, ACETAMINOPHEN, DECADRON. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5926079-3
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 06, 2008. Female patient was diagnosed with breast cancer metastatic, depression , gastric ulcer, hypertension, hypoaesthesia, headache  and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: enterocolitis, gastroenteritis , neutrophil count decreased. Trastuzumab dosage: 186 MG, QD. During the same period patient was treated with TAXOTERE, SEPAZON, TAGAMET, DOXAZOSIN MESYLATE, NORVASC, DEPAS, CALONAL, DECADRON. Patient was hospitalized. Patient recovered.